
Exploring Advancements in Higher-Risk MDS
Published: | Updated:
Despite recent setbacks in clinical trials, there is still hope for improving treatments for high-risk myelodysplastic syndromes.
Ana Alfonso-Piérola, MD, PhD, is an associate clinical professor faculty of medicine at Clinica Universidad de Navarra in Pamplona, Spain

Despite recent setbacks in clinical trials, there is still hope for improving treatments for high-risk myelodysplastic syndromes.

Published: September 18th 2024 | Updated: October 3rd 2024